BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5608968)

  • 1. [Therapy of tinea pedis. Theoretical and experimental data].
    Moretti G; Bertamino R; Crovato F
    Minerva Dermatol; 1967 Jul; 42(7):320-7. PubMed ID: 5608968
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenesis and treatment of hyperkeratotic tinea pedis in Japan.
    Tanuma H
    Mycoses; 1999 Apr; 42(1-2):21-8. PubMed ID: 10394843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Well-Demarcated, Scaly Plaques.
    Milam EC; Meehan SA; Ramachandran S
    JAMA; 2016 Feb; 315(5):508-9. PubMed ID: 26836734
    [No Abstract]   [Full Text] [Related]  

  • 4. Tinea pedis resulting from Fusarium spp.
    Romano C; Gianni C
    Int J Dermatol; 2002 Jun; 41(6):360-2. PubMed ID: 12100693
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel two-step kit for topical treatment of tinea pedis--an open study.
    Shemer A; Grunwald MH; Davidovici B; Nathansohn N; Amichai B
    J Eur Acad Dermatol Venereol; 2010 Sep; 24(9):1099-101. PubMed ID: 20136678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case for diagnosis. Pigmented foot lesion].
    Fond L; Godard W; Perrot JL; Michel JL; Misery L; Montelimard N; Boucheron S; Cambazard F
    Ann Dermatol Venereol; 1999 Apr; 126(4):341-2. PubMed ID: 10421939
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost of topical products for tinea pedis.
    Med Lett Drugs Ther; 2010 May; 52(1337):35-6. PubMed ID: 20431521
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness and tolerability of a standardized extract from Ageratina pichinchensis on patients with tinea pedis: an explorative pilot study controlled with ketoconazole.
    Romero-Cerecero O; Rojas G; Navarro V; Herrera-Arellano A; Zamilpa-Alvarez A; Tortoriello J
    Planta Med; 2006 Nov; 72(14):1257-61. PubMed ID: 17051456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical inquiries. What is the most effective treatment for tinea pedis (athlete's foot)?
    Markova T
    J Fam Pract; 2002 Jan; 51(1):21. PubMed ID: 11927056
    [No Abstract]   [Full Text] [Related]  

  • 10. Short-duration therapy for superficial tinea infections.
    Elewski BE
    Am Fam Physician; 1994 May; 49(6):1349-50. PubMed ID: 8172031
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical butenafine for tinea pedis.
    Med Lett Drugs Ther; 1997 Jul; 39(1004):63-4. PubMed ID: 9217695
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of long-term tinea pedis with miconazole. Double-blind clinical evaluation.
    Brugmans JP; Van Cutsem JM; Thienpont DC
    Arch Dermatol; 1970 Oct; 102(4):428-32. PubMed ID: 4919243
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of the patients with epidermophytosis pedis].
    Glukhen'kiĭ TT; Shugaĭlo VT; Iaremenko II
    Vrach Delo; 1967 Feb; 2():88-91. PubMed ID: 5617034
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness and tolerability of a standardized phytodrug derived from Solanum chrysotrichum on Tinea pedis: a controlled and randomized clinical trial.
    Herrera-Arellano A; Rodríguez-Soberanes A; de los Angeles Martínez-Rivera M; Martínez-Cruz E; Zamilpa A; Alvarez L; Tortoriello J
    Planta Med; 2003 May; 69(5):390-5. PubMed ID: 12802717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs for athlete's foot and tinea cruris.
    Med Lett Drugs Ther; 1976 Nov; 18(24):101-2. PubMed ID: 1036605
    [No Abstract]   [Full Text] [Related]  

  • 16. A controlled study of haloprogin and tolnaftate in tinea pedis.
    Carter VH
    Curr Ther Res Clin Exp; 1972 Jun; 14(6):307-10. PubMed ID: 4625803
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy.
    Del Rosso JQ
    J Am Osteopath Assoc; 1996 Oct; 96(10):607-9. PubMed ID: 8936929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical sertaconazole (ertaczo)--another azole for tinea pedis.
    Med Lett Drugs Ther; 2004 Jun; 46(1185):50-1. PubMed ID: 15211288
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro antifungal susceptibility of dermatophyte strains causing tinea pedis and onychomycosis in patients with non-insulin-dependent diabetes mellitus: a case-control study.
    Ozcan D; Seçkin D; Demirbilek M
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1442-6. PubMed ID: 20384680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental and clinical investigation on oxiconazole.
    Wu SX; Shen YN; Yan N; Guo NR; Liu LL; Yang JQ
    Chin Med J (Engl); 1989 Aug; 102(8):644-6. PubMed ID: 2517622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.